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 SCIENTIFIC OPINION  
Scientific Opinion on safety and efficacy of cobalt compounds (E3) as feed 
additives for all animal species:  
Cobaltous acetate tetrahydrate, basic cobaltous carbonate monohydrate 
and cobaltous sulphate heptahydrate, based on a dossier submitted by 
TREAC EEIG
1 
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
2,3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Cobalt(III) is a component of cobalamin. Its essentiality as trace element results from the capacity of certain 
animal species to synthesise cobalamin by the gastrointestinal microbiota. Feeding supplemental cobalt from the 
additives under application up to the maximum total content in feed set in EU is considered safe for all animal 
species/categories; margin of safety is around 10. Cobalt is predominantly excreted via faecal route. Absorbed 
cobalt follows aqueous excretion routes. About 43 % of body cobalt is stored in muscle; however, kidney and 
liver  are  the  edible  tissues  containing  the  highest  cobalt  concentrations  and  are  most  susceptible  reflecting 
dietary  cobalt concentrations.  In  animals  with  capacity  to  synthesise  cobalamin,  cobalt  is  also deposited  in 
tissues  as  vitamin  B12.  Cobalt(II)  cations  are  genotoxic  under  in  vitro  and  in  vivo  conditions,  and  have 
carcinogen,  mutagen  and  reproduction  toxicant  (CMR)  properties.  No  data  are  available  on  the  potential 
carcinogenicity of cobalt(II) following oral exposure. However, oral exposure may potentially entail adverse 
threshold-related  effects  in  humans.  The  estimated  population  intake  of  cobalt  most  likely  includes  the 
contribution of foodstuffs from animals fed cobalt-supplemented feedingstuffs. An increase in cobalt exposure 
by the use of cobalt-containing feed additives is therefore not expected. Considering the population exposure to 
cobalt, about 4–10 times lower than the health-based guidance value, no safety concern for the consumer is 
expected for threshold effects of oral cobalt. The cobalt(II) compounds assessed are considered skin and eye 
irritants and dermal/inhalatory sensitisers. Their dust is a hazard to persons handling these substances. Exposure 
by inhalation must be avoided. The use of cobalt from any source at the authorised maximum content in feed 
does not provide a risk to the environment. The compounds assessed are available for cobalamin synthesis in the 
rumen and therefore effective in ruminants; this conclusion is extrapolated to horses and rabbits. 
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SUMMARY 
Following  a  request  from  the  European  Commission,  the  Panel  on  Additives  and  Products  or 
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and 
efficacy of the following cobalt compounds as feed additives for all animal species: cobaltous acetate 
tetrahydrate, basic cobaltous carbonate monohydrate and cobaltous sulphate heptahydrate. 
The only physiological role of cobalt in target animals is that of a component of vitamin B12. The 
significance of cobalt(II) as an essential trace element results from the capacity of certain animal 
species to synthesise sufficient quantities of vitamin B12 by the gastrointestinal microbiota. 
Feeding supplemental cobalt in form of the additives under application up to the  maximum total 
content in feed set by EU legislation is considered safe for all animal species/categories. The margin 
of safety is around 10. 
The apparent absorption of cobalt from cobalt chloride measured in laboratory animals was in the 
range of 13 to 34 %. Cobalt is predominantly excreted via the faecal route. Absorbed cobalt follows 
aqueous excretion routes, via kidney but also via milk. About 43 % of body cobalt is stored in muscle; 
however, kidney and liver are the edible tissues containing the highest cobalt concentrations and most 
susceptible to increase such concentrations as a response to increased cobalt concentrations in feed. In 
animals with the capacity to synthesise cobalamin, cobalt is also deposited in tissues in the form of 
vitamin B12. Most cobalt in offal and muscle tissues of ruminants can be attributed to vitamin B12. The 
fraction  of  vitamin  B12-bound  cobalt  is  smaller  in  hindgut  fermenters  (horses  and  rabbits)  and 
considerably smaller in poultry and pork meat, and particularly in milk and eggs indicating dietary 
supply of cobalt as such.  
Correlations  between  cobalt/vitamin  B12  intake  at  physiological  feed  concentrations  and  tissue 
deposition as cobalt(II)/cobalt(III) could not be established owing to lack of data. Any prediction of 
the cobalt content of food of animal origin from dietary cobalt is therefore not possible at present. 
Cobalt(II) cations are considered genotoxic under in vitro and in vivo conditions. Cobalt(II) cations 
have CMR (carcinogen, mutagen and reproduction toxicant) properties. No data are available on the 
potential carcinogenicity of cobalt(II) following oral exposure either in humans or in experimental 
animals. However, oral exposure may potentially entail a number of adverse effects in humans (effects 
on heart, erythropoiesis and thyroid and prenatal development, as well as allergic dermatitis). For 
these threshold effects, the FEEDAP Panel developed a health-based guidance value of 0.0016 mg/kg 
body weight (bw) and day.  
The estimated population average intake of cobalt was reported to be 0.005–0.04 mg Co/day in the 
USA, 0.011 mg Co/day in Canada, 0.012 mg/day in the UK, and 0.029 mg Co/day in France. These 
figures most likely include already the contribution of foodstuffs from animals fed feedingstuffs that 
are routinely supplemented with cobalt(II) compounds. An increase of cobalt exposure resulting from 
the use of cobalt-containing feed additives is therefore not to be expected. 
Considering the population exposure to cobalt, which is about 4–10 times lower than the health-based 
guidance value, no safety concern for the consumer is expected for threshold effects of oral cobalt at 
the current intake level. However, considering the toxicological profile of cobalt(II) and its salts, and 
the uncertainties regarding the deposition and the speciation of cobalt (cobalt(II) or vitamin B12) in 
foodstuffs of animal origin, the FEEDAP Panel confirms its previous position that it would be prudent 
to limit the cobalt (cobalt(II) cation) supplementation of feedingstuffs to a level lower than the current 
maximum authorised. 
The cobalt(II) compounds under application are considered as skin and eye irritants and as dermal and 
inhalatory  sensitisers.  The  compounds  have  a  varying  dusting  potential.  Considering  their Three cobalt compounds for all species 
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toxicological  profile,  their  dust  is  a  hazard  to  persons  handling  these  substances.  Exposure  by 
inhalation must be avoided. 
The use of cobalt from any source at the currently maximum authorised concentration in feed will not 
result in a substantial increase of the concentration in the environment and no further environmental 
risk assessment is deemed necessary. 
Cobalt(II)  diacetate  tetrahydrate,  cobalt(II)  carbonate  hydroxide  (2:3)  monohydrate,  and  cobalt(II) 
sulphate heptahydrate, are considered as sources of available cobalt for microbial synthesis of vitamin 
B12 in the gastrointestinal tract. The additives are therefore considered as effective nutritional additives 
for ruminants. This conclusion can be extrapolated to horses and rabbits. 
The FEEDAP Panel made some recommendations particularly for (i) the restriction of the use of 
cobalt(II)-containing additives to ruminants, horses and rabbits, (ii) the reduction of the maximum 
total  cobalt  content  to  1 mg/kg  complete  feed  and  (iii)  the  limitation  of  handling  the  additive  to 
premixture industry. Three cobalt compounds for all species 
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BACKGROUND  
Regulation  (EC)  No  1831/2003
4  establishes the rules governing the  Community  authorisation of 
additives for use in animal nutrition.  In particular, Article 4(1) of that Regulation lays down that any 
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an 
application in accordance with Article 7.  Article 10(2) of that Regulation also specifies that for 
existing products within the meaning of Article 10(1), an application shall be submitted in accordance 
with Article 7, at the latest one year before the expiry date of the authorisation given pursuant to 
Directive 70/524/EEC for additives with a limited authorisation period, and within a maximum of 
seven years after the entry into force of this Regulation for additives authorised without a time limit or 
pursuant to Directive 82/471/EEC. 
The  European  Commission  received  a  request  from  the  Consortium  TREAC  EEIG
5  for  (i) 
authorisation of a new use (in water for drinking), and/or (ii) re-evaluation of authorisation, of cobalt-
containing  additives  when  used  as  feed  additives  for  all  animal  species  (category:  Nutritional 
additives; functional group: compounds of trace elements). 
According  to  Article  7(1)  of  Regulation  (EC)  No  1831/2003,  the  Commissio n  forwarded  the 
applications  to the European Food Safety Authority (EFSA) as a n  application under Article 4(1) 
(authorisation of a feed additive or new use of a feed additive)  and under Article 10(2) (re-evaluation 
of an authorised feed additive). EFSA received directly from the applicants the technical dossiers in 
support of this application.
6 According to Article 8 of that Regulation, EFSA, after verifying the 
particulars and documents submitted by the applicant, shall undertake an assessment in order to 
determine whether the feed additive complies with the conditions laid down in Article 5. The 
particulars and documents in support of the application were considered valid by EFSA as of  16 
November 2011.
7 
The additives cobaltous acetate tetrahydrate, basic cobaltous carbonate monohydrate and cobaltous 
sulphate heptahydrate had been authorised in the European Union (EU) under the element Cobalt-Co 
for all animal species  ―Without a time limit‖ (Commission Regulation (EC) No 1334/2003)
8 and a 
maximum content of 2 mg/kg complete feedingstuff . Following the provisions of Article 10(1) of 
Regulation (EC) No 1831/2003 the compounds  were included in the EU Register of Feed Additives 
under the category ―Nutritional additives‖ and the functional group ―Compounds of trace elements‖.
9  
EFSA issued an opinion on the use of cobalt compounds as additives in animal nutrition (EFSA, 
2009a). More recently the FEEDAP Panel has delivered an opinion on the safety and efficacy of 
cobalt carbonate 46 % as feed additive for ruminants, horses and rabbits (EFSA, 2012a). 
TERMS OF REFERENCE  
According to Article 8 of Regulation (EC) No 1831/2003, EFSA shall determine whether the feed 
additives comply with the conditions laid down in Article 5. EFSA shall deliver an opinion on the 
safety for the target animal(s), consumer, user and the environment and the efficacy of  cobaltous 
acetate  tetrahydrate,  basic  cobaltous  carbonate  monohydrate  and  cobaltous  sulphate  heptahydrate 
when  used  under  the  conditions  described  in  Table  1.
                                                       
4   Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use 
in animal nutrition. OJ L 268, 18.10.2003, p. 29. 
5  TREAC EEIG – Trace Elements Authorisation Consortium.Avenue Louise 120, Box 13. 1050 Brussels – Belgium. This 
application involves 4 companies, which have been nominated in the text as follows: (A) OGM Kokkola Chemicals Oy; 
(B) Shepherd Widnes Ltd.; (C) Umicore; (D) Todini and Co. S.p.a. 
6  EFSA Dossier reference: FAD-2010-0337.  
7  A new mandate was received in EFSA on 13/04/2011. 
8  Commission Regulation (EC) No 1334/2003 of 25 July 2003 amending the conditions for authorisation of a number of 
additives in feedingstuffs belonging to the group of trace elements. OJ L 187, 26.7.2003, p. 11. 
9  European Union Register of Feed Additives pursuant to Regulation (EC) No 1831/2003 
http://ec.europa.eu/food/food/animalnutrition/feedadditives/comm_register_feed_additives_1831-03.pdf Three cobalt compounds for all species 
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Table 1:  Description and conditions of use of the additive as proposed by the applicant  
Additive   Cobalt  
Registration number/EC No/No (if appropriate)  3b3.xx 
Category(-ies) of additive  3. Nutritional additives 
Functional group(s) of additive  b. Compounds of trace elements 
 
Description 
Composition, description  Chemical formula  Purity criteria 
(if appropriate) 
Method of analysis 
(if appropriate) 
Cobaltous acetate, 
tetrahydrate. 23% Co 
Basic cobaltous carbonate, 
monohydrate. 50% Co 
Cobaltous sulphate, 
heptahydrate. 20% Co 
Co(CH3COO)2•4H2O 
 
 
2CoCO3•3Co(OH)2•H2O 
 
CoSO4•7H2O 
 
Complies with 
EU law on 
undesirable 
substances 
EN 15510:2007 
EN ISO 6869:2000 
 
Trade name (if appropriate)  Not appropriate 
Name of the holder of authorisation (if appropriate)  TREAC EEIG 
 
Conditions of use for Cobaltous acetate, tetrahydrate 23% Co; Basic cobaltous carbonate, monohydrate 
50% Co; Cobaltous sulphate, and heptahydrate 20% Co to use in feedingstuffs and for Cobaltous 
acetate, tetrahydrate 23% Co and Cobaltous sulphate, heptahydrate 20% Co water for drinking. 
Species  or 
category  of 
animal 
Maximum 
Age 
Minimum content  Maximum content  Withdrawal 
period 
(if appropriate)  mg/kg of complete feedingstuffs 
All animal species 
and categories  -  -  All animal species or 
categories: 2 (total)  Not appropriate 
    mg/litre water for drinking   
All animal species 
and categories  -  -  All animal species or 
categories: 1 (total)  Not appropriate 
 
Other provisions and additional requirements for the labelling 
Specific conditions or restrictions for 
use (if appropriate) 
For the additives to use in feedingstuffs: The additive shall be 
incorporated in feeds in form of a premixture. 
For the additives to use in water for drinking: Not appropriate 
Specific conditions or restrictions for 
handling (if appropriate) 
For user safety: breathing protection, safety glasses and gloves 
should be worn during handling 
Post-market monitoring  
(if appropriate)  Not appropriate (existing feed additive) 
Specific conditions for use in 
complementary feedingstuffs  
(if appropriate) 
The cobalt feed additive is given continuously during animal 
rearing. 
 
Maximum Residue Limit (MRL) (if appropriate) 
Marker residue  Species or category of 
animal 
Target tissue(s) or 
food products 
Maximum content in 
tissues 
Not appropriate  Not appropriate  Not appropriate  Not appropriate 
 Three cobalt compounds for all species 
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ASSESSMENT 
This  opinion  is  based  in  part  on  data  provided  by  a  consortium  of  companies  involved  in  the 
production/distribution of cobalt-containing compounds. It should be recognised that this data covers 
only  a  fraction  of  the  existing  cobalt-containing  additives.  The  Panel  has  sought  to  use  the  data 
provided together with data from other sources to deliver an opinion. 
1.  Introduction 
Cobalt (Co) is a metallic element occurring in the most common compounds in the +2 or +3 oxidation 
states. Cobalt(III) is the central atom of cobalamin (vitamin B12), representing about 4.3 % of the 
molecular weight. Cobalt salts have been commonly used for many years in animal nutrition. Six 
cobalt salts are currently authorised in the EU (Commission Regulation (EC) No 1334/2003)
10 as feed 
additives  ( cobalt  acetate  tetrahydrate ,  basic  cobalt  carbonate  monohydrate ,  cobalt  chloride 
hexahydrate,  cobalt  nitrate  hexahydrate ,  cobalt  sulphate  monohydrate   and  cobalt  sulphate 
heptahydrate)  for  all  animal  species  with  a  total  maximum  content  of  2  mg  Co/kg  complete 
feedingstuffs. 
The current application concerns  to cobalt acetate tetrahydrate, basic cobalt carbonate monohydrate 
and  cobalt  sulphate  heptahydrate   as  nutritional  additives,  functional  group  compounds  of  trace 
elements for use in feed for all animal species, and for  cobalt acetate tetrahydrate and cobalt sulphate 
heptahydrate for use in water for drinking.  
EFSA commissioned a study by the University of Ge nt (Belgium) of selected trace and ultratrace 
elements who submitted a technical report to EFSA (Van Paemel et al., 2010); cobalt was included in 
this study. Information from this report has been used in this opinion. 
A previous opinion of the FEEDAP Panel (EFSA, 2009a) on the risk assessment of the use of cobalt 
compounds in animal nutrition considered (i) the necessity of cobalt supplementation for the different 
target species including potential adverse effects of minimising/withdrawing cobalt supplement ation 
on animal health, (ii) the safety for consumers of foods from animals treated with cobalt salts, and (iii) 
the safety of persons handling cobalt compounds as feed additives. The current opinion summarises 
and updates the relevant sections, for details see the above-mentioned opinion. 
In a previous opinion, the FEEDAP Panel (EFSA, 2009 a) reviewed the toxicological data of cobalt 
available in the public literature,  and adopted for threshold-related effects the health-based guidance 
value set by the US Agency for Toxic Substances and Disease Registry for intermediate oral exposure 
(≥ 365 days) (ATSDR, 2010). In an opinion of the French Food Safety Agency (formerly AFSSA and 
now  ANSES)  regarding  the  migration  of  cobalt  from  porcelain  oven  dishes  intended  to  come  in 
contact  with  food  (AFSSA,  2010),  AFSSA  considered  also  the  FEEDAP’s  2009  opinion.  In  the 
current opinion, the FEEDAP Panel considered this assessment together with others in the light of the 
recently adopted default values for  uncertainty factors (UFs) of the EFSA’s Scientific Committee 
(EFSA, 2012b). Since the proposal for a health-based guidance value is not in the focus of the terms of 
reference, this consideration is given in Appendix (Appendix B). 
1.1.  Other uses of cobalt 
At present no cobalt sources/forms are authorised in the EU in the manufacture of food supplements. 
The EFSA’s Scientific Panel on Additives and Nutrient Sources added to Food (ANS Panel) assessed 
the  safety  of  cobalt(II)  chloride  hexahydrate  for  nutritional  purposes  (EFSA,  2009b).  The  Panel 
considered that the proposed uses of this compound in food supplements were of safety concern.  
                                                       
10   Commission Regulation (EC) No 1334/2003 of 25 July 2003 amending the conditions for authorisation of a number of 
additives in feedingstuffs belonging to the group of trace elements. OJ L 187, 26.7.2003, p. 11. Three cobalt compounds for all species 
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Cobalt is listed in the fertiliser Regulation as micro-nutrient essential for plant growth.
11 
In the USA, the following cobalt compounds are allowed in animal feeds: cobalt acetate, cobalt 
carbonate, cobalt chloride, cobalt cho line citrate complex, cobalt glucoheptonate, cobalt gluconate, 
cobalt oxide, cobalt sulphate, cobalt amino acid com plex, cobalt amino acid chelate   and  cobalt 
proteinate (AAFCO, 2010). 
1.2.  Biological role of cobalt 
The FEEDAP Panel summarised in a previous opinion (EFSA, 2009a) the biological role of cobalt as 
follows: 
―The only known essential role of cobalt in animals and humans is being a component of vitamin B12 
as Co(III). Absorbed cobalt per se, Cobalt(II), is not known to have any biological function. 
Cobalt is an essential trace element for ruminants and horses, which can synthesise vitamin B12 in the 
digestive  tract  by  microbial  action.  The  efficiency  of  incorporation  of  cobalt  in  vitamin  B12  in 
ruminants is low and inversely related to cobalt intake. Incorporation rate may be characterized by a 
range of 3 to 15 %. Besides covering the requirements for vitamin B12 synthesis, cobalt may play a role 
in rumen fermentation by increasing fibre digestion from low quality forages. 
Non-ruminants require the intake of vitamin B12 because they lack the ability to synthesise the vitamin 
in  significant  amounts  by  digestive  tract  microbiota.  However,  pigs  and  poultry  are  known  to 
synthesise small amounts of this vitamin by hindgut bacteria, which is why coprophagous animals 
may receive some supply of vitamin B12 from microbial fermentation.‖ 
2.  Characterisation 
For compounds of trace elements, the element itself is considered the active substance. 
2.1.  Characterisation and identity of the additives 
Within the TREAC consortium, cobalt acetate tetrahydrate is represented by one company (company 
B), basic cobalt  carbonate monohydrate by three companies (companies  A, B and C), and cobalt 
sulphate heptahydrate by two companies (companies A and D).
12 
2.1.1.  Cobalt acetate tetrahydrate 
Cobalt acetate tetrahydrate (Co(CH3COO)2 x 4H2O; molecular weight: 249.08 Da; CAS No: 6147-53-
1), is available as violet to red granules/crystals with a vinegar like odour. It is soluble in water (38 
g/100 mL at 20°C). It contains by specification 23 24 % cobalt (theoretical value: 23.66 % cobalt). 
The analysis of five batches showed an average of 23.8±0.1 % cobalt.
13 
Three batches were analysed for heavy metals, arsenic and dioxins. The maximum values were 2.6 mg 
Cd/kg, 6.6 mg Pb/kg, 0.1 mg Hg/kg, and 0. 036 ng WHO-PCDD/F-TEQ/kg; arsenic was below the 
limit of detection.
14, 15 All values complied with the thresholds set by EU legislation.
16 
                                                       
11   Regulation (EC) No 2003/2003 of the European Parliament and of the Council of 13 October 2003 relating to fertilisers. 
OJ L 304, 21.11.2003, p. 1. 
12   See footnote 5. 
13   Technical Dossier/Section II/Annex 2-1-7. 
14   Technical Dossier/Section II/Annex 2-1-16, for heavy metals and arsenic. 
15   Technical Dossier/Section II/Annex 2-1-21, for dioxins. 
16   The following target values set by Directive 2002/32/EC of the European Parliament and of the Council on undesirable 
substances in animal feed are taken for comparison: As 30 mg/kg compounds of trace elements, Pb 100 mg/kg compounds 
of trace elements, Cd 10 mg/kg compounds of trace elements and Hg 0.3 mg/kg calcium carbonate; dioxins 1.0 ng WHO-
PCDD/F-TEQ/kg, sum of dioxins plus dioxin-like PCBs 1.5 ng WHO-PCDD/F-PCB-TEQ/kg compound of trace elements. Three cobalt compounds for all species 
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The bulk density was 827 ± 29 g/L (five batches).
17 The analysis of p article size of five batches 
showed a maximum of 0.41 % particles with a diameter < 50 μm.
18  
A saturated cobalt acetate solution is obtained by adding acetic acid to a cobalt source of sufficient 
purity to meet the specification. The solution is subsequently crystallised (by acting on temperature), 
centrifuged and dried to obtain the animal feed grade cobalt acetate. 
2.1.2.  Basic cobaltous carbonate monohydrate 
Basic cobalt carbonate monohydrate has the chemical formula: 2CoCO3 x 3Co(OH)2 x H2O. The CAS 
number  provided  by  the  applicant  (513-79-1)  is  that  for  cobalt  carbonate  (CoCO3).  Since  three 
cobalt(II)  carbonate  hydroxides  exist,  two  of  them  also  sharing  the  same  synonym  (basic  cobalt 
carbonate), the correct name
19 for the compound under application  is cobalt(II) carbonate hydroxide 
(2:3) monohydrate with the CAS  No. 51839-24-8 (molecular weight: 534.7 Da) and should be used. 
The compound is a pink, odourless powder, insoluble in water. It  contains by specification 50 53 % 
cobalt  (theoretical  value:  55.1 %).  The  analysis  of  23  batches  showed  an  average  of  51.9±0.7 % 
cobalt.
20 
All companies provided data for heavy metals and arsenic ; one (company C) out of the three for 
dioxins. The maximum values of  products from  companies A and B (eight batches) were 3.6 mg 
Cd/kg, 12 mg Pb/kg, <0.1 mg Hg/kg, <1 mg As/kg and 0.75 ng  PCDD/F (WHO-TEQ)/kg (eight 
batches).
21, 22 All values complied with the thresholds set by EU legislation.
23 
Bulk density ranges from 480 to 871 g/L (n=17).
24 In two products of companies A and C  about 95 
and 98 %, respectively, of particles (v/v) in the additive had a diameter of about <50 μm (n=1 each 
product);
25 in the additive of company  B only about 3 % (v/v) were < 50 µm (n= 5).
26 The dusting 
potential of the product with a high amount of fine particles  was 2.9 and 4.3 g/m³ in two batches 
(Stauber-Heubach method; company A).
27  
Cobalt carbonate  is produced by adding sodium carbonate to a  cobalt sulphate solution . After 
adjusting the pH, the cobalt carbonate will precipitate, the slurry is filtered and  washed with water. 
The cobalt carbonate is then spray dried. Control measures are in place. 
2.1.3.  Cobalt sulphate heptahydrate 
Cobalt sulphate heptahydrate (CoSO4 x 7H2O; molecular weight: 281.1 Da; CAS No: 10026-24-1), 
appears as pink to red/brown, odourless crystals and is soluble in water (36.2 g/100 mL at 20°C). It 
contains by specification 20-21 % cobalt (theoretical value: 20.96 %). The analysis of 15 batches 
showed an average of 20.6±0.3 % cobalt.
28 
The companies provided data for  undesirable substances (10 batches in total). For heavy metals and 
arsenic, the maximum values found were 1.3 mg Cd/kg, 3.3 mg Pb/kg, <  0.1 mg Hg/kg and < 1 mg 
As/kg. For dioxins and the sum of dioxins plus dioxin -like PCBs the values reported (five batches) 
                                                       
17   Technical Dossier/Section II/Annex 2-2-3. 
18   Technical Dossier/Section II/ Annex 2-2-7. 
19   IARC Monographs, Volume 52, 1991, last updated: 17 November 1997. 
20   Technical Dossier/Section II/Annexes 2-1-8, 2-1-9 and 2-1-10. 
21   Technical Dossier/Section II/Annexes 2-1-15, 2-1-16 and 2-1-17 for heavy metals and arsenic. 
22   Technical Dossier/Section II/Annexes 2-1-22, 2-1-23 and 2-1-24 for dioxins. 
23   See Footnote 16. 
24   Technical Dossier/Section II/Annexes 2-2-2, 2-2-3 and 2-2-4. 
25   Technical Dossier/Section II/Annexes 2-2-8 and 2-2-10, respectively. 
26   Technical Dossier/Section II/Annex 2-2-9. 
27  Technical Dossier/Section II/Annex 2-2-13. 
28   Technical Dossier/Section II/Annexes 2-1-11 and 2-1-12. Three cobalt compounds for all species 
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were 0.13 ng WHO PCDD/F-TEQ/kg and 0.04 ng WHO-PCDD/F-PCB-TEQ/kg, respectively.
29,30 All 
values complied with the thresholds set by EU legislation. 
The bulk density ranges from 1052 to 1183 g/L (n=6).
31 The critical particle size fraction < 50 µm 
amounted to about 96 % (v/v) in the additive of company A (one batch), and to 13 % (v/v) in the 
product  of  company  D  (one  batch).  The  dusting  potential  (Stauber-Heubach)  of  two  batches  of 
company A with fine powder was 0.4 and 0.8 g/m
3.
32 
The production of c obalt  sulphate heptahydrate, feed grade is based on a cobalt solution as raw 
material which is obtained by liquid-liquid extraction process. The solution is stored in a feeding silo 
and it is further sent to crystallization unit where cobalt sulphate crystals are obtained. 
2.2.  Stability and homogeneity 
Stability studies are not required for inorganic compounds of trace elements.  
Three products of cobalt carbonate hydroxide monohydrate (1 batch/company), and two batches of 
cobalt sulphate heptahydrate (1/company), were incorporated via premixture into two piglet feeds of a 
conventional composition.
33 Target concentration was 2 mg Co/kg complete feed. Ten subsamples 
were analysed for each feed, mixing quality was controlled by Microtracer FFS -red. At an excellent 
mixing quality (Microtracer recovery 100 %), the CVs for the basic cobalt carbonate were 7.3, 6.3, and 
4.0 %. The CVs for cobalt sulphate were 9.8 and 11.0 %. 
A similar procedure was applied to cobalt acetate tetrahydrate which was incorporated in a piglet feed 
with the target concentration of 2 mg Co/kg. A microtracer recovery of 103 % indicated excellent 
mixing quality. The CV of the cobalt concentration from the acetate in ten subsamples was 3.9 %.
34 
2.3.  Physico-chemical incompatibilities in feed 
According  to  the  current  knowledge,  no  incompatibilities  resulting  from  the  use  of  the  cobalt 
compounds under assessment in compound feed are likely to be expected. 
2.4.  Conditions of use  
The cobalt compounds under application, cobalt acetate tetrahydrate, cobalt(II) carbonate hydroxide 
(2:3) monohydrate and cobalt sulphate heptahydrate, are intended to be used for all animal species at a 
maximum (total) concentration in complete feed of 2 mg Co/kg. The applicant proposed to incorporate 
the cobalt compounds in feedingstuffs via premixtures. 
Although the applicant originally requested the use of cobalt acetate tetrahydrate and cobalt sulphate 
heptahydrate  in  water  for  drinking,  the  Consortium  considered  later  the  use  of  the  two  cobalt 
compounds as not anymore relevant to the application.
35 Consequently this route of supplementation 
was not further assessed.  
2.5.  Evaluation of the analytical methods by the  European Union Reference Laboratory 
(EURL) 
EFSA has verified the EURL report as it relates to the methods used for the control of the cobalt 
compounds  under  assessment  in  animal  feed.  The  Executive  Summary  of  the  EURL  report  is  in 
Appendix A. 
                                                       
29   Technical Dossier/Section II/Annexes 2-1-18 and 2-1-19 for heavy metals and arsenic. 
30   Technical Dossier,/Section II/Annexes 2-1-25 and 2-1-26 for dioxins. 
31   Technical Dossier/Section II/Annexes 2-2-5 and 2-2-6. 
32   Technical Dossier/Section II/Annex 2-2-13. 
33   Technical Dossier/Section II/Annex 2-4-3. 
34   Supplementary information/Annex 1. 
35   Supplementary information. Three cobalt compounds for all species 
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3.  Safety 
The paragraphs below on the safety of cobalt for target animals and consumers have been taken and 
summarised from a previous FEEDAP opinion (EFSA, 2009a). Additional information, which updates 
the mentioned opinion, has been considered and referenced in the current opinion. 
3.1.  Safety for the target species 
3.1.1.  Dietary requirement 
A specific requirement for cobalt per se is not established. The dietary requirement/allowances of 
ruminants and horses for cobalt intended to optimise the vitamin B12 supply is in the range of 0.1–0.25 
mg/kg complete feedingstuff.  
Considering low cobalt average background levels in feedingstuffs (< 0.1–0.5 mg/kg dry matter (DM), 
plant feed materials showing lowest values), feed supplementation is generally needed to cover the 
requirement. In general, a cobalt supplementation of 0.3 mg/kg DM is considered sufficient.  
Other  animal  species  than  ruminants,  rabbits  and  horses  do  not  need  dietary  cobalt,  but  do  need 
vitamin B12. 
3.1.2.  Tolerance 
The tolerance of ruminants to cobalt is very high and greatly in excess of the requirements. The US 
National Research Council (NRC) set 25 mg/kg feed as maximum tolerable level of cobalt for cattle, 
poultry, sheep and horses and 100 mg/kg feed for swine (NRC, 2005). According to  current  EU 
legislation, feed for all animal species is not allowed to exceed 2 mg total Co/kg complete feed. 
Typical signs of chronic cobalt toxicity in most species are reduced feed intake and body weight, 
emaciation,  anaemia,  hyperchromaemia,  debility  and  increased  liver  cobalt  (NRC,  1980).  Cobalt 
toxicity  in  cattle  is  characterized  by  mild  polycythaemia;  excessive  urination,  defecation  and 
salivation;  shortness  of  breath;  and  increased  haemoglobin  (Hb),  red  cell  count  and  packed  cell 
volume (NRC, 1996). Sheep seems to be more resistant to cobalt overdoses than cattle, and young 
ruminants without rumen function are more sensitive to cobalt overdoses than adults. 
Therefore, it would be considered unlikely that cobalt toxicity in target animals could be a major 
problem in practice. However, Murray (2010) reported some field cases of cobalt toxicosis in calves 
and  concluded  that  supplementation  of  animals  with  minerals  should  be  based  on  evidence  of 
deficiency supported by laboratory confirmation. Signs of chronic cobalt toxicity are similar in many 
respects  to  deficiency.  Administration  of  additional  or  higher  doses  in  order  to  compensate  the 
apparent  deficiency  would  further  deteriorate  the  clinical  symptoms.  The  author  concluded  that 
supplementing diets of non-deficient animals, and failure to adhere to recommended dosages, is at best 
wasteful but is also potentially fatal. 
Corrier et al. (1986) administered different cobalt doses from cobalt chloride hexahydrate (equivalent 
to 0, 120 and 180 mg/kg feed from day 1 to 70; and 0, 400 and 600 mg supplemental Co/kg diet from 
day 71 to 108) to adult sheep. The authors observed a numerical decrease in weight gain at both cobalt 
doses,  but  no  differences  in  haematological  or  biochemical  determinations.  Neither  gross  nor 
microscopic lesions were found in the testes or other tissues. Cobalt concentration in liver and kidney 
increased from 0.09 (both tissues) to about 8.6 and 2.0 mg Co/kg wet tissue, respectively, without 
differences  between  the  two  cobalt  doses  administered.  However,  the  results  differ  from  other 
previous studies (Becker and Smith, 1951) which reported that daily doses between 4 and 11 mg 
Co/kg bw caused anaemia, severe anorexia, weight loss, acute toxicosis and mortality. Three cobalt compounds for all species 
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3.1.3.  Interactions in vivo 
There appears to be a considerable variation in cobalt tolerance in animals. Several dietary factors (i.e. 
protein, sulphydryl-compounds, iron, selenium and vitamin E) and age may affect the level of cobalt 
necessary to cause overt toxicosis (NRC, 2005).  
3.1.4.  Conclusions on the safety for target species  
Feeding supplemental cobalt from the cobalt compounds under assessment up to the maximum total 
cobalt content in feed set by current EU legislation (2 mg Co/kg complete feed) is considered safe for 
all animal species/categories. The margin of safety is around 10. 
3.2.  Safety for the consumer  
3.2.1.  Metabolic fate 
The metabolic fate of cobalt and vitamin B12 (cobalamin) was already described in a previous opinion 
of the FEEDAP Panel (EFSA, 2009a), and it is summarised below. 
In laboratory animals such as rats and mice, the reported apparent absorption of cobalt from cobalt 
chloride  was  in  a  range  of  13 34 %.  Cobalt  is  predominantly  excreted  via  the  faecal  route,  and 
includes  mainly  the  unabsorbed  fraction.  Absorbed  cobalt  follows  aqueous  excretion  routes,  via 
kidney but also via milk. Urinary cobalt is considered a good indicator of exposure to soluble cobalt, 
but not to insoluble cobalt compounds. 
The microflora of the rumen (of cattle, sheep and goat) and of the large hindgut fermenters (horses and 
rabbits) synthesize vitamin B12 if sufficient quantities of available cobalt were orally provided. Only 
about  40  %  of  the  apparent  ruminally  synthesised  cobalamin  reaches  the  lower  intestine.  The 
degradation products without vitamin B12 activity reaching the intestine are poorly absorbed. The 
intestinal  disappearance  (difference  between  duodenal  and  ileal  supply)  indicated  an  apparent 
absorption of cobalamin of about 45 %. 
In animals with the capacity to synthetize cobalamin, cobalt from orally administered cobalt(II) is 
consequently also deposited in tissues in the form of vitamin B12. 
3.2.2.  Tissue deposition 
About 43 % of body cobalt is stored in muscles. However, kidneys and liver are the edible tissues 
containing the highest cobalt concentrations; these organs also reflect the cobalt intake.  
Among foodstuffs of animal origin, offal shows the highest cobalt content: liver with about 0.02 0.07 
mg/kg fresh weight (FW), followed by kidney with about 0.001 0.01 mg/kg FW. Meat is in the range 
of 0.001 0.02 mg/kg FW as are fillets of freshwater fish. Milk and eggs contain about 0.004 0.005 
mg Co/kg; dairy products like cheese and butter are relatively rich in cobalt (0.02 mg/kg FW). Most 
cobalt in offal and muscle tissue of ruminants can be attributed to vitamin B12. This fraction of vitamin 
B12-bound cobalt is probably already smaller in hindgut fermenters (such as horses and rabbits, since 
only cobalt not absorbed in the small intestine is available for vitamin B12 synthesis in the hindgut), 
and considerably smaller in poultry and pork meat (about 20 to 40 %) indicating dietary supply of 
cobalt as such. Eggs and milk contain even higher amounts of vitamin B12-unrelated cobalt (about 70 
and 95 %, respectively) indicating excretion of absorbed soluble cobalt. However, these are estimates 
with  several  uncertainties  due  to  methodological  reasons  (e.g.  poor  data  set,  analytical  methods). 
Correlations  between  cobalt/vitamin  B12  intake  at  physiological  feed  concentrations  and  tissue 
deposition could not be established by the FEEDAP Panel owing to lack of data. Any prediction of the 
cobalt content of food of animal origin from dietary cobalt is therefore not possible at present. Three cobalt compounds for all species 
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3.2.2.1.  Quantitative relations 
Male  rats  were  given  a  protein  restricted  diets  for  eight  weeks  (Clyne  et  al.,  1988),  either  non-
supplemented or supplemented with 20 mg CoSO4x7H2O/kg body weight (~ 4 mg Co/kg). Cobalt 
supplementation resulted in a significant decrease in weight gain, and an increase of cobalt in the 
myocardium (1.615 vs. 0.051 mg/kg), muscle tissue (0.483 vs. 0.019 mg/kg) and in serum (0.124 vs. 
0.001 mg/kg). 
Henry et al. (1997) studied on a total of 27 mature wethers (59.8 kg bw) the effect of increasing 
dietary cobalt concentrations (0, 20, and 40 mg supplemental Co/kg feed from CoSO4xH2O, the basal 
diet contained 0.17 mg Co/kg) on tissue deposition for 60 days. The addition of cobalt had no effect on 
feed intake. The cobalt concentration in liver (control 0.20 mg/kg DM) responded to increasing dietary 
cobalt (3.74 and 7.33 mg Co/kg DM with 20 and 40 mg supplemental dietary cobalt, respectively) as 
did kidney (0.77 vs. 3.27 and 4.82 mg/kg DM), muscle (0.13 vs. 0.59 and 1.26 mg/kg DM) and heart.  
3.2.2.2.  A survey of foodstuffs of animal origin in the USA 
Coleman  et  al.  (1992)  published  data  on  the  cobalt  concentration  of  muscle,  liver,  and  kidney 
specimens in the USA, collected at slaughter from 2314 animals of 17 animal species/categories for 
one  year  (1985-1986).  They  analysed  muscle,  liver  and  kidneys  of  about  328  calves,  286 
heifers/steers, 95 bulls/cows, 162 lambs, 34 sheep, 318 pigs, 280 boars/sows, 311 young chicken, 306 
mature chicken, 61 turkeys and 11 ducks. The limit of quantification (LOQ) was 0.15 mg Co/kg tissue 
FW. They found quantifiable cobalt levels in about 1.9 % of muscle, 24 % of liver, and 15 % of kidney 
specimens.
36 Mean values were between 0.20 and 0.23 mg Co/kg muscle (exception 1.92 mg/kg for 
four specimens  from heifer/steer), 0.22 and 0.27 mg Co/kg liver (exception 1.15 mg/kg for 54 
specimens from bull/cow) and between 0.22 and 0.28 mg Co/kg kidney without essential differences 
between  animal  species/categories.  When  calculating  the  specimen s  without  quantifiable  cobalt 
concentrations, considering the LOQ (worst case assumption), mean  cobalt concentrations in muscle, 
liver, and kidney of 0.15, 0.17, and 0.16 mg Co/kg, respectively, could be suggested. 
3.2.3.  Toxicological studies 
The  FEEDAP  Panel  reviewed  extensively  the  available  toxicity  data  (EFSA,  2009a).  The  Panel 
summarised: 
―According  to  Regulation  (EC)  No  790/2009  amending  Regulation  (EC)  No  1272/2008,  cobalt 
dichloride and cobalt sulphate are of low acute toxicity (category 4), but are classified as respiratory 
and skin sensitizers (category 1), as acute and chronic toxicants to the aquatic environment (category 
1) and as presumed human carcinogens by the inhalatory route (class 1B). Cobalt(II) cations are also 
considered  genotoxic  under  in  vitro  and  in  vivo  conditions.‖  No  data  are  available  in  the  open 
literature on the potential carcinogenicity of cobalt following the exposure via the oral route either in 
humans or in experimental animals.  
The EFSA´s ANS Panel concluded in 2009 that ―Given the toxicological profile of cobalt(II) chloride 
hexahydrate, including genotoxicity and carcinogenicity, the Panel concludes that the proposed uses of 
cobalt(II) chloride hexahydrate added for nutritional purposes in food supplements as a source of 
cobalt are of safety concern‖ (EFSA, 2009b). 
The most recent assessment has been published by the European Chemicals Agency (ECHA) in 2010 
as  support  documents  for  the  identification  of  cobalt(II)  carbonate,  cobalt(II)  diacetate,  cobalt(II) 
                                                       
36   Exact figures as follows: 
  - Muscle specimens (quantifiable/total): calf (5/327), heifer/steer (4/287), bull/cow (2/95), lamb (1/165), sheep (2/34), pig 
(10/324), boar/sow (2/280), young chicken (9/311), mature chicken (3/308), turkey (2/61), duck (4/111). 
  - Liver specimen (quantifiable/total): calf (107/327), heifer/steer (91/287), bull/cow (54/95), lamb (40/164), sheep (12/34), 
pig (58/324), boar/sow (82/281), young chicken (29/309), mature chicken (51/309), turkey (16/60), duck (17/111).  
  - Kidney specimen (quantifiable/total): calf (70/328), heifer/steer (31/286), bull/cow (9/95), lamb (25/162), sheep (7/34), 
pig (34/318), boar/sow (15/280), young chicken (47/311), mature chicken (43/306), turkey (5/61), duck (66/111). Three cobalt compounds for all species 
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dinitrate, cobalt(II) sulphate and cobalt dichloride as substances of very high concern (SVHC) because 
of  their  carcinogen,  mutagen  and  reproduction  toxicant  (CMR)  properties  (ECHA  2008;  ECHA 
2010a d). The support documents cover also the hydrated forms of the cobalt salts. 
For cobalt(II) carbonate (EC No: 208-169-4, CAS No: 513-79-1), cobalt(II) diacetate (EC No: 200-
755-8, CAS No: 71-48-7) and cobalt(II) sulphate (EC No: 233-334-2, CAS No: 10124-43-3), the 
following classification according to Regulation (EC) No 1272/2008
37 was made: 
May cause cancer by inhalation (carcinogen 1B), suspected of causing genetic defects (mutagen 2), 
may damage fertility (reproduction toxicant 1B). May cause allergy or asthma symptoms or breathing 
difficulties if inhaled, may cause an allergic skin reaction.  Very toxic to aquatic life, very toxic to 
aquatic life with long lasting effects. 
On 20
th December 2011, the ECHA published a recommendation
38 for the inclusions of substances in 
Annex  XIV  (―List  of  substances  subject  to  authorisation‖)  of  Regulation  (EC)  No  1907/2006,
39 
prioritising thirteen substances from the Candidate List of SVHC. Among them is cobalt(II) carbonate, 
cobalt(II) sulphate, cobalt(II) diacetate, cobalt(II) dinitrate and cobalt dichloride. 
3.2.4.  Assessment of consumer safety 
The FEEDAP Panel summarised in 2009 (EFSA, 2009a): 
―The estimated population average intake of cobalt was reported to be  0.012  mg/day in the UK, 
0.005–0.04 mg Co/day in the US, 0.011 mg Co/day in Canada, and 0.029 mg Co/day in France. The 
FEEDAP Panel, based on its own calculations, concluded that the potential cobalt intake of consumers 
from food of animal origin would not exceed 14 µg/day.‖ 
The  estimated  population  intakes  most  likely  include  already  the  contribution  of  foodstuffs  from 
animals fed feedingstuffs routinely supplemented with cobalt(II) compounds. An increase of cobalt 
exposure by the use of cobalt containing feed additives is therefore not to be expected. 
Considering that dietary exposure to cobalt is about 4 10 times lower than the health-based guidance 
value (see Appendix B), no safety concern for the consumer is expected for threshold effects of oral 
cobalt at the current intake level. 
However,  considering  (i)  the  toxicological  profile  of  cobalt(II)  and  its  salts,  (ii)  the  scarcity  of 
deposition data, particularly for milk and eggs, and (iii) the uncertainties regarding the speciation of 
cobalt  (cobalt(II)  or  vitamin  B12)  in  foodstuffs  of  animal  origin,  the  FEEDAP  Panel  confirms  its 
previous position that it would be prudent to limit the cobalt (cobalt(II) cation) supplementation of 
feedingstuffs to a level lower than the current maximum authorised. 
3.3.  Safety for the users/workers 
Any exposure of users to the cobalt(II) salts under application may be of concern, considering the 
toxicological  profile  of  cobalt(II)  compounds  under  application  and,  particularly,  their  CMR 
properties. They should be considered as skin and eye irritants, as well as sensitisers to the skin and 
the respiratory tract.  
                                                       
37   Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, 
labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and 
amending Regulation (EC) No 1907/2006. OJ L 353, 31.12.2008, p. 1. 
38   http://echa.europa.eu/documents/10162/17232/backgroundoc_cobalt_carbonate_en.pdf  
39   Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the 
Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals 
Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation 
(EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 
93/105/EC and 2000/21/EC. OJ L 396, 30.12.2006, p. 1. Three cobalt compounds for all species 
 
 
EFSA Journal 2012;10(7):2791  16 
Particle  size  (inhalable  and  respirable  fraction)  and  dusting  potential  of  the  cobalt(II)  salts  under 
application are therefore of particular relevance. 
3.3.1.  Hazard by inhalation 
In two products of basic cobalt carbonate monohydrate (companies A and C), the fraction of particles 
< 50 µm amounted to about 95 and 98 %; in the additive of a third company (B) only to about 3 %. 
Among the two cobalt sulphate heptahydrate products, in one 96 % of all particles had a diameter of < 
50 µm, in the other only 13 %. For the cobalt acetate tetrahydrate, the fraction of particles with a 
diameter < 50 µm was only 0.4 %. However, these data are all based on one batch per company only, 
their representativeness is therefore limited. A conservative assessment has to consider a worst case 
scenario resulting from the highest dusting potential measured with 2.9 and 4.3 g/m
3 for two basic 
cobalt carbonate monohydrate products.  
For pulmonary effects, the ATSDR has developed a minimum risk level of 0.1 μg Co/m
3 air (ATSDR, 
2010). The few data submitted indicate a dusting potential of the basic cobalt carbonate monohydrate 
of 1 450 000 and 2 150 000 µg Co/m³ air. All values exceed by orders of magnitude the ATSDR 
thresholds.  
3.3.2.  Conclusions 
The cobalt(II) compounds under application are considered as skin and eye irritants and as dermal and 
inhalatory sensitisers.  
The compounds have a varying dusting potential. However, the few data which could be considered 
indicate that the thresholds set by the ATSDR for inhalation exposure are exceeded. Due to the CMR 
properties of the additives, their dust is a hazard to persons handling the substance. Exposure by 
inhalation must be avoided. 
3.4.  Safety for the environment 
Based  on  the  calculation  method  provided  in  the  technical  guidance  (EFSA,  2008),  the  highest 
increase of cobalt in soil is around 40 µg/kg after a one year application of manure assuming that 
100 % of a dose (2 mg Co from any source /kg complete feed) will be excreted. According to the 
database of the Forum of European Geological Surveys
40 the median total  cobalt content (ICP-MS 
analysis) in Europe is 8.97 mg/kg
 in subsoil and 7.78 mg/kg
 in topsoil, with a range varying from < 3 
to 170 mg/kg
 in subsoils and up to 249 mg/kg
 in topsoils.  
The FEEDAP Panel therefore concluded that the use of the cobalt from any source at the currently 
maximum  authorised  dose  will  not  result  in  a  substantial  increase  of  the  concentration  in  the 
environment and no further environmental risk assessment is deemed necessary.  
4.  Efficacy 
The only known essential role of cobalt in animals and humans is being a component of vitamin B12 as 
cobalt(III). Absorbed cobalt per se, cobalt(II), is not known to have any biological function. 
The FEEDAP Panel previously concluded that monogastric animals (including poultry and fish) do 
not require cobalt but vitamin B12 (EFSA, 2009a). Consequently, there is no need for any  cobalt 
supplementation to the feed for these animals.  
The ruminal microflora can synthesize vitamin B12, provided dietary cobalt is available in sufficient 
quantities. Consequently, the vitamin B12 requirement of these animals can be covered by dietary 
cobalt. The host metabolism of ruminants requires also only vitamin B12. A comparable conclusion 
may be drawn for horses and coprophagous rabbits (hindgut fermentation of vitamin B12), although 
there is a lack of quantitative data. 
                                                       
40   http://www.gsf.fi/foregs/geochem/ Three cobalt compounds for all species 
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4.1.  Bioavailability of cobalt compounds 
Kawashima et al. (1997) studied on the basis of a previous experiment (Henry et al., 1997) in three 
trials the relative bioavailability of seven cobalt sources in ruminants (sheep) compared to reagent 
grade CoSO4 x 6/7H2O (23.1 % cobalt). The basal diet provided adequate cobalt to the animals. Cobalt 
deposition in liver and kidney was taken as the parameter. The cobalt sources were cobalt carbonate 
feed grade (FG, 45.2 % cobalt), cobalt carbonate reagent grade (REG, 48.4 % cobalt), cobalt heptonate 
(4.1 % cobalt), cobalt oxide (FG, 70 % cobalt), cobalt oxide (RG, 72.5 % cobalt) and a cobalt oxide by-
product (BP) (25.6 % cobalt, > 21.7 % manganese, 10 % zinc and 9 % calcium).  
Both  carbonates  were  more  available  the  the  oxides.  The  ranges  of  the  relative  figures  for 
bioavailability (cobalt sulphate= 100) were for carbonate FG 87 141 %, carbonate RG 68 133 %, for 
the oxide BP 37 58 %, for oxide FG 7 24 %, for oxide RG 0 7 %, and for the heptonate 80 92 %. 
4.2.  Conclusions on efficacy 
Taking into account the cited literature investigating cobalt(II) carbonates and cobalt(II) sulphate and 
other literature, the cobalt acetate tetrahydrate, the basic cobalt carbonate monohydrate and the cobalt 
sulphate  heptahydrate  are  considered  as  efficacious  sources  of  cobalt  which  are  in  turn  used  for 
microbial fermentation of vitamin B12. Evidence of the efficacy of these cobalt compounds is therefore 
given for ruminants and can be extrapolated to horses and rabbits. 
The  FEEDAP  Panel  reiterates  its  previous  conclusion  (EFSA,  2009a)  that  the  potential  cobalt 
supplementation to diets for ruminants, horses and rabbits of 0.3 mg/kg DM and a maximum content 
of 1 mg Co/kg complete feed is considered appropriate, taking into account that the cobalt background 
concentrations of feed materials do not exceed 0.5 mg/kg DM of complete feed. 
5.  Post-market monitoring 
The  FEEDAP  Panel  considers  that  there  is  no  need  for  specific  requirements  for  a  post-market 
monitoring  plan  other  than  those  established  in  the  Feed  Hygiene  Regulation
41  and  Good 
Manufacturing Practice. 
CONCLUSIONS AND RECOMMENDATIONS 
The additives under application are: cobalt(II) diacetate tetrahydrate, cobalt(II) carbonate hydroxide 
(2:3) monohydrate, and cobalt(II) sulphate heptahydrate.  
The  only  physiological  role  of  cobalt  is  being  a  component  of  vitamin  B12.  The  significance  of 
cobalt(II) as essential trace element results from the capacity of certain animal species to synthesise 
sufficient quantities of vitamin B12 by gastrointestinal microbiota. 
CONCLUSIONS 
Feeding supplemental cobalt  in form of the additives under application  up to the  maximum total 
content in feed set by EU legislation is considered safe for all animal species/categories. The margin 
of safety is around 10. 
The apparent absorption of cobalt from cobalt chloride measured in laboratory animals was in a range 
of  13  to  34 %.  Cobalt  is  predominantly  excreted  via  the  faecal  route,  and  includes  mainly  the 
unabsorbed fraction. Absorbed cobalt follows aqueous excretion routes, via kidney but also via milk. 
About  43 % of  body  cobalt  is  stored in  muscle;  however,  kidney  and  liver are the  edible  tissues 
containing the highest cobalt concentrations and most susceptible to increase such concentrations as a 
consequence to increased cobalt concentrations in feed. In animals with the capacity to synthesise 
                                                       
41   Regulation (EC) No 183/2005 of the European Parliament and of the Council of 12 January 2005 laying down 
requirements for feed hygiene. OJ L 35, 8.2.2005, p. 1. Three cobalt compounds for all species 
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cobalamin, cobalt from orally administered cobalt(II) is also deposited in tissues in form of vitamin 
B12. 
Most cobalt in offal and muscle tissues of ruminants can be attributed to vitamin B12. The fraction of 
vitamin  B12-bound  cobalt  is  smaller  in  hindgut  fermenters  (horses  and  rabbits)  and  considerably 
smaller in poultry and pork meat, and particularly in milk and eggs indicating dietary supply of cobalt 
as such. Correlations between cobalt/vitamin B12 intake at physiological feed concentrations and tissue 
deposition as Co(II)/Co(III) could not be established due to lack of data. Any prediction of the cobalt 
content of food of animal origin from dietary cobalt is therefore not possible at present. 
Cobalt(II) cations are considered genotoxic under in vitro and in vivo conditions. Cobalt(II) cations 
have CMR (carcinogen, mutagen and reproduction toxicant) properties. No data are available on the 
potential carcinogenicity of cobalt(II) following oral exposure either in humans or in experimental 
animals.  However,  oral  exposure  may  potentially  entail  a  number  of  adverse  effects  in  humans 
(cardiac  effects,  effects  on  erythropoiesis,  effects  on  thyroid,  developmental  effects  and  allergic 
dermatitis). For these threshold effects, the FEEDAP Panel developed a health-based guidance value 
of 0.0016 mg/kg bw and day (see Appendix B). 
The estimated population average intake of cobalt was reported to be 0.005–0.04 mg Co/day in the 
US, 0.011 mg Co/day in Canada, 0.012 mg/day in the UK, and 0.029 mg Co/day in France. These 
figures  most  likely  include  already  the  contribution  of  foodstuffs  from  animals  fed  feedingstuffs 
routinely  supplemented  with  cobalt(II)  compounds. An  increase  of  cobalt  exposure  by  the  use  of 
cobalt containing feed additives is therefore not to be expected. 
Considering the population exposure to oral cobalt which is about 4 to 10 times lower than the health-
based guidance value, no safety concern for the consumer is expected for threshold effects of oral 
cobalt. 
The cobalt(II) compounds under application are considered as skin and eye irritants and as dermal and 
inhalatory  sensitisers.  The  compounds  have  a  varying  dusting  potential.  Considering  their 
toxicological  profile,  their  dust  is  a  hazard  to  persons  handling  these  substances.  Exposure  by 
inhalation must be avoided. 
The  FEEDAP Panel  concludes  that the  use  of  cobalt  from  any  source  at  the  currently  authorised 
maximum  content  in  feed  will  not  result  in  a  substantial  increase  of  the  concentration  in  the 
environment and no further environmental risk assessment is deemed necessary. 
Cobalt(II)  diacetate  tetrahydrate,  cobalt(II)  carbonate  hydroxide  (2:3)  monohydrate,  and  cobalt(II) 
sulphate heptahydrate, are considered as sources of available cobalt for microbial synthesis of vitamin 
B12 in the gastrointestinal tract. The additives are therefore considered as effective nutritional additives 
for ruminants. This conclusion can be extrapolated to horses and rabbits. For other animal species, in 
particular poultry, pigs and fish, dogs and cats, no evidence for any function as compounds of an 
essential trace element was provided by the applicant or could be found in literature. 
RECOMMENDATIONS 
The FEEDAP Panel recommends the following corrections and improvements in the description of the 
additives under application:  
The  denomination  of  cobalt  acetate  tetrahydrate,  should  be  corrected  to  cobalt(II)  diacetate 
tetrahydrate. 
The  denomination  of  basic  cobaltous  carbonate  monohydrate  should  be  changed  to  cobalt(II) 
carbonate hydroxide (2:3) monohydrate, to describe a distinctive identity. 
Equally, the cobalt sulphate heptahydrate should be nominated cobalt(II) sulphate, heptahydrate. Three cobalt compounds for all species 
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The applicant proposed for cobalt acetate tetrahydrate, basic cobalt carbonate monohydrate and cobalt 
sulphate heptahydrate, as specification for heavy metals and arsenic the mandatory thresholds of the 
EU legislation. With regard to the analytical data, the FEEDAP Panel proposes a reduction of these 
values to < 20 mg/kg for Pb, < 5 mg/kg for Cd and < 2 mg/kg for As. 
With  regard  to  a  further  amendment  of  Directive  2002/32/EC,  the  FEEDAP  Panel  gives  to 
consideration to transfer the above figures for heavy metals and arsenic as maximum contents for 
Co(II) diacetate, carbonate hydroxide (2:3) and sulphate. 
The  FEEDAP  Panel  reiterates  its  recommendations  from  the  previous  opinion.  Considering  the 
toxicological profile of cobalt(II) containing compounds, the FEEDAP Panel recommends to minimize 
the  exposure  of  users  to  cobalt(II)  compounds  at  several  levels  of  feed  formulation  and  animal 
nutrition. 
The FEEDAP Panel recommends modifying the authorisation of cobalt compounds in feedstuffs by: 
restricting the use of cobalt compounds as additives to feed for ruminants (except milk replacer), 
horses and rabbits; 
reducing the authorised total maximum cobalt content from 2 to 1 mg/kg complete feed for all species 
except fish;  
limiting cobalt supplementation in feed for ruminants (except milk replacer), horses and rabbits to a 
maximum of 0.3 mg Co/kg complete feed. 
No negative consequences of these measures on animal health and the efficiency of animal production 
are expected. 
The  FEEDAP  Panel  recommends  further  a  modification  of  the  conditions  of  use  of  cobalt(II) 
containing compounds: 
The  incorporation  into  feed  should  be  only  allowed  via  premixtures  considering  (i)  the  low 
incorporation rate into feed and (ii) the better equipment of premixture manufacturers for handling 
hazardous substances.  
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APPENDICES 
APPENDIX A  
Executive Summary of the Evaluation Report of the European Union Reference Laboratory for Feed 
Additives on the Method(s) of Analysis for Cobalt (E3)
1 
In the current application authorisation is sought under  articles 4(1) and 10(2) for Cobaltous acetate, 
tetrahydrate;  Cobaltous  carbonate,  basic  Cobaltous  carbonate,  monohydrate;  Cobaltous  sulphate, 
heptahydrate under the category of "nutritional additives" functional group 3b (compounds of trace 
elements),  according  to  the  classification  system  of  Annex  I  of  Regulation  (EC)  No  1831/2003. 
Specifically, authorisation is sought for the use of the feed additives for all categories and species. 
The Applicants stated minimum total cobalt contents of 23% in Cobaltous acetate, tetrahydrate; 45% 
in  Cobaltous  carbonate  and/or  basic  Cobaltous  carbonate,  monohydrate;  and  20%  in  Cobaltous 
sulphate, heptahydrate. 
The  feed  additives  are  intended  to  be  incorporated  into  premixtures,  feedingstuffs  and  water. 
Applicants (FAD-2010-0227 and FAD-2010-0371) suggested maximum levels of total cobalt of 2 
mg/kg  feedingstuffs  and  1  mg/L  water  to  comply  with  the  limits  set  in  Regulations  (EC)  No 
1334/2003.  Applicant  (FAD-2010-0402)  took  into  consideration  the  EFSA  Scientific  opinion 
recommending to reduce the maximum level of Cobalt to 1 mg/kg feedingstuffs. 
For the identification of the various cobalt compounds in the feed additives the EURL recommends the 
general  identification  tests  of  acetates,  carbonates  and  sulphates,  described  in  the  European 
Pharmacopoeia (Monograph 01/2008:20301). Additionally the EURL recommends crystallographic 
techniques, such as X-Ray diffraction, for the characterisation of crystalline structure of Cobaltous 
acetate, tetrahydrate; Cobaltous carbonate, basic Cobaltous carbonate, monohydrate and Cobaltous 
sulphate, heptahydrate.  
For the determination of total cobalt in the feed additive, premixtures and feedingstuffs the Applicants 
submitted internationally recognised ring trial validated methods EN 15510 and CEN/TS 15621. Both 
methods are based on inductively coupled plasma atomic emission spectroscopy (ICP-AES), with or 
without pressure digestion. Similar performance characteristics were reported for the two methods 
mentioned above: – a relative standard deviation for repeatability (RSDr) ranging from 2.5 to 12 %; - a 
relative standard deviation for reproducibility (RSDR) ranging from 11 to 26 %; and – a limit of 
quantification (LOQ) around 0.7 mg/kg feedingstuffs. Based on these performance characteristics the 
EURL recommends for official control the two CEN methods (EN 15510 and CEN/TS 15621), based 
on ICP-AES, to determine total cobalt content in the feed additive, premixtures and feedingstuffs. 
Furthermore, the EURL recommends the ring-trial validated CEN method EN ISO 11885, based on 
inductively coupled plasma optical (atomic) emission spectroscopy (ICP-AES) for the quantification 
of total cobalt in water. 
Further  testing  or  validation  of  the  methods  to  be  performed  through  the  consortium  of  National 
Reference Laboratories as specified by Article 10 (Commission Regulation (EC) No 378/2005) is not 
considered necessary. 
                                                       
1  The full report is available on the EURL website: http://irmm.jrc.ec.europa.eu/SiteCollectionDocuments/FinRep-
CobaltGroup.pdf Three cobalt compounds for all species 
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APPENDIX B  
The FEEDAP Panel of EFSA adopted in 2009 a scientific opinion on the use of cobalt compounds as 
additives in animal nutrition (EFSA, 2009). In this opinion, the Panel also reviewed the literature on 
threshold related adverse effects of oral cobalt intake. The Panel noted that the exposure to cobalt via 
the  oral  route  may  potentially  entail  a  number  of  adverse  in  effects  in  humans  (effects  on  heart, 
erythropoiesis, thyroid and prenatal development as well as allergic dermatitis). An increase in the 
erythrocyte  number  in  humans,  obtained  by  orally  administering  cobalt  (as cobalt  chloride)  at  an 
average daily rate of about 1 mg/kg bw to volunteers for 22 days (Davis and Fields, 1958), was 
considered the most sensitive biological effect linked to repeated oral exposure to the metal. The 
FEEDAP Panel adopted the conclusion of the ATSDR that the lowest observed effect level (LOAEL) 
obtained from this study could be taken to derive a minimum risk level of 0.01 mg Co/kg bw and day 
for intermediate duration (≤ 365 days) of cobalt exposure, applying a UF of 100 (10 for intra-human 
variability and 10 for the use of a LOAEL) (ATSDR, 2004). The LOAEL of 1 mg Co/kg bw and day 
was  considered  as  confirmed  by  an  8-week  study  in  rats  administered  cobalt  chloride  which 
established a no observed adverse effect level (NOAEL) of 0.6 mg Co/kg bw and day (Stanley et al., 
1947).  
In an opinion of the French Food Safety Agency (formerly AFSSA and now ANSES) considering the 
migration  of  cobalt  from  porcelain  oven  dishes  intended  to  come  in  contact  with  food,  it  was 
concluded: With respect to the health-based guidance values applicable to cobalt and in light of the 
few available studies on oral exposure, the Tolerable Daily Intake could be between 0.0016 and 0.008 
mg/kg bw/day, for threshold toxic effects (AFSSA, 2010).  
In its opinion, AFSSA considered also the FEEDAP opinion (EFSA, 2009) and mentioned that an 
uncertainty factor could however have been applied to the ATSDR Minimum Risk Level value to take 
into account subacute to chronic exposure extrapolation. AFSSA continued indicating that the value 
used in the REACH guidance documents for this extrapolation is 6, which brings the (tolerable) daily 
oral intake (from 0.01 mg/kg bw down) to 0.0016 mg/kg bw.  
The AFSSA noted further that the use of the rat study by Stanley et al. (1947) with an inter-species 
factor of 4 (rats to human) and an intra-species factor of 10 leads to a final value of 0.016 mg/kg 
bw/day.  An  additional  factor  of  at  least  2  should  however  be  applied  to  take  into  account  the 
extrapolation from subchronic exposure (90 days) to chronic exposure (lifetime). This leads to a final 
value smaller than 0.008 mg Co/kg bw/day (the rat study lasted 56 days). 
The AFFSA added: However the genotoxicity data do not allow the possibility of non-threshold toxic 
effects to be ruled out. Lacking oral carcinogenesis studies, the Threshold of Toxicological Concern 
could be applied for this type of effect. 
Other health-based guidance values 
The Dutch National Institute of Public Health and the Environment (RIVM) derived a tolerable daily 
intake  of  0.0014  mg  Co/kg  bw  and  day  from  a  LOAEL  of  0.04  mg  Co/kg  bw  and  day  for 
cardiomyopathy after intermediate exposure in beer drinkers applying a safety factor of 30 (3 for intra-
human variability and 10 for extrapolation to a NOAEL) (RIVM, 2001). 
The Expert Group on Vitamins and Minerals (EVM) based its guidance level of 0.023 mg/kg bw and 
day - which would not be expected to result in any adverse effects - on a LOAEL of 23 mg/kg bw and 
day obtained in a 13-week study in mice using spermatogenesis as endpoint (EVM, 2003). An UF of 
1000 was applied (10 for inter-species variation, 10 for inter-individual variation and 10 for LOAEL to 
NOAEL  extrapolation).  However,  AFSSA  considered  that  according  the  REACH  technical 
documents, the LOAEL-to-NOAEL extrapolation factor should be 3 (or 10), the inter-species factor 7 
(for mice), the subchronic-to-chronic exposure extrapolation factor 2 and the intra-species factor 10, 
which leads to a total factor 1400 to 420. The guideline value would then be between 0.0164 and 
0.0548 mg Co/kg bw/day. Three cobalt compounds for all species 
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Cobalt health-based guidance values and population exposure to cobalt 
Table B1 shows the different health-based guidance values adopted by various scientific bodies and 
calculated for a 70-kg adult person (EFSA, 2012). 
Table B1. Cobalt health-based guidance values for a 70-kg person   
Scientific body  mg Co/day 
ATSDR/FEEDAP    0.700 
AFSSA lower value    0.112  
AFSSA higher value    0.560  
RIVM       0.098 
EVM      1.610 
AFSSA corrected EVM, low value    1.148 
AFSSA corrected EVM, high value    3.836 
 
Some available estimates of the population intake for cobalt are 0.012 mg Co/day and person from a 
Total Diet Study in the UK (MAFF, 1997), and about 0.0 11 mg Co/day and person for the US 
population  (ATSDR,  2004).  All  exposure  data  are  considerably  below  the  health-based  guidance 
values (Table B1).  
Assessment 
It should be noted that the minimum risk level derived by ATSDR/FEEDAP was not foreseen for 
lifetime  exposure.  Its  use  was  expressively  limited  to  an  intermediate  duration  (≤  365  days)  of 
exposure. The AFSSA calculation intends to extrapolate for lifetime exposure, which is different to the 
above  and  not  comparable.  However,  the  FEEDAP  Panel  acknowledges  the  need  to  derive  a 
harmonised guidance value for chronic exposure to cobalt.  
The FEEDAP Panel wishes to highlight that any extrapolation from a subacute study to a health-based 
guidance value for lifetime exposure is difficult and increases the margin of uncertainty. A recent 
guidance for this extrapolation from the EFSA’s Scientific Committee is now available (EFSA, 2012). 
AFSSA, ATSDR and the FEEDAP Panel agree that polycythaemia is the most sensitive endpoint for 
threshold cobalt effects. 
For the extrapolation from subchronic to chronic study duration in rodents, the EFSA’s Scientific 
Committee  recommends  the  use  of  an  UF  of  2,  considering  the  extent  of  investigations  usually 
performed in 90-day studies. The EFSA’s Scientific Committee indicated in its opinion that it was not 
in a position to propose default values for the extrapolation from subacute to chronic study duration in 
rodents, due to differences in the respective study designs. 
In  accounting  for  the  absence  of  a  NOAEL,  the  Scientific  Committee  recommends  to  use  the 
benchmark procedure. If the benchmark procedure cannot be applied to the critical toxicological study 
(as is the case, individual data of the publication of Davis and Fields (1958) are not accessible), the 
LOAEL approach might be used and an additional UF will be needed, the size of which should be 
determined on a case-by-case basis and justified. Several organisations recommend in their guidelines, 
e.g. Guidelines for drinking water quality (WHO, 2011), the application of an additional UF of up to 
10 to the LOAEL to derive a health-based guidance value.  
Considering the study on human volunteers (Davis and Fields, 1958) with a LOAEL of 1 mg Co/kg 
bw and day and applying the recommendations and data given in the Scientific Committee guidance 
document, the following UFs can be applied: 10 for inter human variability, 10 for extrapolation from 
subacute to chronic and 6 for extrapolation from LOAEL to NOAEL. The total UF is then 600. A 
health-based guidance for chronic exposure for threshold related toxic effects would be 0.0016 mg 
Co/kg bw and day (equivalent to 0.12 mg Co/day for an adult 70-kg person, figure rounded following 
the recommendations of the Scientific Committee).  Three cobalt compounds for all species 
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Considering the rat study (Stanley et al., 1947) with a NOAEL of 0.6 mg Co/kg bw and day and 
applying the Scientific Committee recommendations, the following UFs were applied: 10 for inter-
species variability, 10 for intra-species variability and 4 for extrapolation from subchronic (8-week 
study)  to  chronic.  The  total  UF  is  then  400.  A  health-based  guidance  for  chronic  exposure  for 
threshold related toxic effects would be 0.0015 mg Co/kg bw and day (equivalent to 0.1 mg Co/day 
for  an  adult  70-kg  person,  figure  rounded  following  the  recommendations  of  the  Scientific 
Committee). 
The values for a health-based guidance level for chronic exposure to oral cobalt for threshold related 
toxic  effects  derived  from  the  two  relevant  studies  considered  in  the  previous  FEEDAP  opinion 
(EFSA, 2009) are similar (0.0016 (derived from the human study, Davis and Fields, 1958) and 0.0015 
mg/kg bw and day (derived from the rat study, Stanley et al., 1947)). The value derived from the 
human study is equal to the AFSSA proposal.  
The FEEDAP Panel adopts 0.0016 mg Co/kg bw and day (corresponding to a daily intake of 0.12 mg 
for a 70-kg adult person) as a health-based guidance value. Considering the population exposure to 
oral cobalt which is about 4 to 10 times lower than the health-based guidance value, no safety concern 
for the consumer is expected for threshold effects of cobalt. 
The FEEDAP Panel principally agrees with AFSSA when noting that the genotoxicity data do not 
allow to rule out the possibility of non-threshold toxic effects for cobalt(II). However, applying the 
threshold of toxicological concern (TTC) concept (TTCgenotoxic 0.15 µg/person and day) would lead to 
0.0025 µg Co/kg bw and day (about thousand folds lower than the proposed health-based guidance 
value); for several reasons this seems inappropriate. Cobalt occurs naturally in food of plant and 
animal origin. The estimated population average intake of cobalt is reported to be in the range of 5 40 
µg/person and day. Even a complete withdrawal of cobalt from animal nutrition would not reduce the 
population exposure to the magnitude required for the TTCgenotoxic to be met.  
For some animal species (ruminants and, probably, horses and rabbits) cobalt is an essential trace 
element  for  vitamin  B12  synthesis.  A  (not  fully  quantifiable)  part  of  cobalt  in  animal  tissues  and 
products is cobalt(III) in cobalamin and, as such, is indispensable to human nutrition. Nevertheless, 
any reasonable measure to reduce cobalt(II) content in foodstuffs of animal origin should be taken. 
Considering (i) the toxicological profile of cobalt(II) and its salts, (ii) the scarcity of deposition data, 
particularly for milk and eggs, and (iii) the uncertainties regarding the speciation of cobalt (cobalt(II) 
or vitamin B12) in foodstuffs of animal origin, it would be prudent to limit the cobalt (cobalt(II) cation) 
supplementation of feedingstuffs generally at a lower level and to animals which convert cobalt(II) to 
cobalamin. Therefore the FEEDAP Panel recommends to the European Commission to modify the 
authorisation of cobalt compounds in feedstuffs by (i) restricting the use of cobalt compounds as 
additives to feed for ruminants (except milk replacer), horses and rabbits, (ii) reducing the authorised 
total maximum cobalt content from 2 to 1 mg/kg complete feed for all species except fish, and (iii) 
limiting cobalt supplementation in feed for ruminants (except milk replacer), horses and rabbits to a 
maximum of 0.3 mg Co/kg complete feed. 
Conclusions 
The  FEEDAP  Panel,  following  the  recommendations  of  the  Scientific  Committee,  applies  to  the 
LOAEL (based on polycythaemia) of about 1 mg/kg bw observed in a 22-day study on volunteers an 
UF of 600 (10 for inter human variability, 10 for extrapolation from subacute to chronic and 6 for 
extrapolation  from  LOAEL  to  NOAEL).  This  results  in  a  health-based  guidance  value  of  0.0016 
mg/kg bw and day for threshold effects of oral cobalt, corresponding to a daily oral intake of 0.12 mg 
Co for a 70 kg adult person. 
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ABBREVIATIONS  
AAFCO   Association of American Feed Control Officials 
AFSSA   Agence Française de Sécurité Sanitaire des Aliments (French Food Safety Agency) 
ALT   alanine transaminase 
ANS  EFSA’s Scientific Panel on Additives and Nutrient Sources added to Food 
ANSES   Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du 
Travail 
As  arsenic 
AST  aspartate transaminase 
ATSDR  Agency for Toxic Substances and Disease Registry 
bw  body weight 
Ca  calcium 
CAS  Chemical Abstracts Service 
Cd  cadmium 
CMR  carcinogen, mutagen and reproduction toxicant 
Co  cobalt 
Cr  chromium 
DM  dry matter 
EC  European Commission 
ECHA  European Chemicals Agency  
EFSA  European Food Safety Authority 
EU   European Union 
EURL  European Union Reference Laboratory  
EVM   Expert Group on Vitamins and Minerals  
FEEDAP  EFSA’s Scientific Panel on Additives and Products or Substances used in Animal   Feed 
FG   feed grade 
FW  fresh weight 
Hb  haemoglobin 
HDL  high-density lipoprotein 
Hg  mercury 
Ht  haematocrit 
ICP-AES  inductively coupled plasma atomic emission spectroscopy 
LOAEL  lowest observed adverse effect level 
LOQ   limit of quantification 
MAFF   Ministry of Agriculture Food and Fisheries 
MCH  mean corpuscular haemoglobin 
MCHC  mean corpuscular haemoglobin concentration 
MCV  mean corpuscular volume 
MRL  maximum residue limit 
NRC  National Research Council  
NOAEL  no observed adverse effect level 
Pb   lead 
PCB  polychlorinated biphenyl 
PCDD  polychlorinated dibenzo-para-dioxin 
PCDF  polychlorinated dibenzofuran 
RBC  red blood cell 
REACH   Registration, Evaluation, Authorisation and Restriction of Chemicals 
RIVM   Dutch National Institute of Public Health and the Environment 
RG  reagent grade 
SVHC  substances of very high concern 
TTC  threshold of toxicological concern 
TEQ  toxic equivalent factor 
UF  uncertainty factor 
WBC  white blood cell 
WHO  World Health Organization 